Skip to main navigation Skip to search Skip to main content

Capillary electrophoretic study of carboplatin and analogues with nucleoside monophosphates, di- and trinucleotides

Publications: Contribution to journalArticlePeer Reviewed

Abstract

Carboplatin (cis-diammine-1,1-cyclobutane-dicarboxylatoplatinum(II)) is the only cisplatin (cis-diammine-dichloroplatinum(II)) derivative currently available for the treatment of cancer worldwide. The higher stability of the carboxylate ligand compared to the coordinated chloride in cisplatin results in a reduced reactivity of the molecule. Capillary electrophoresis has been applied for investigating the adduct formation of carboplatin and analogues with nucleoside monophosphates, di- and trinucleotides. Adduct formation results in a significant shift of the absorption maximum to lower energy compared to free nucleotides. Therefore, characterization of the analytes was performed by UV additionally to NMR spectroscopy. A preference for GMP- and AMP-coordination was found. The ability of separating all four common nucleotides and their major platinum adducts in a single run demonstrates the suitability of CE for this kind of investigations. Copyright Œ 2001 Elsevier Science B.V.
Original languageEnglish
Pages (from-to)181-186
Number of pages6
JournalJournal of Inorganic Biochemistry
Volume83
Issue number2-3
DOIs
Publication statusPublished - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

  • 1040 Chemistry

Fingerprint

Dive into the research topics of 'Capillary electrophoretic study of carboplatin and analogues with nucleoside monophosphates, di- and trinucleotides'. Together they form a unique fingerprint.

Cite this